ReviewJournal of clinical medicine2025

Neurofibromatosis Type 1 and MEK Inhibition: A Comprehensive Review with Focus on Selumetinib Therapy.

George Imataka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.